Top stories

View all news

3 December 2021

Gavi Board approves malaria vaccine programme funding, COVAX 2022 strategic approach and measures to maintain, restore and strengthen routine immunisation

A new malaria vaccination programme has been approved, providing Gavi-eligible countries in sub-Saharan Africa a powerful new tool with which to fight malaria.

2 December 2021

Gavi Board approves funding to support malaria vaccine roll-out in sub-Saharan Africa

A new malaria vaccination programme will support Gavi-eligible countries to implement a new tool in the fight against malaria in sub-Saharan Africa in 2022-2025, including vaccine introduction, procurement and delivery

2 December 2021

New Zealand kicks off 2022 COVAX fundraising efforts with NZ$ 9 million funding pledge

One of the first COVAX funders and first dose donors, New Zealand has again stepped up and pledged NZ$ 9 million in funding to the Gavi COVAX Advance Market Commitment (Gavi COVAX AMC). This funding will help COVAX better respond to country needs…

COVAX vaccine roll-out

>589 million COVAX vaccines shipped
OWP
144 participants

As of 2 Dec 2021

COVAX Facility

Gavi is co-leading COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. This involves coordinating the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of COVID-19 vaccines.

Learn more

The COVID-19 vaccine race

Pre-clinical
194vaccines
are being explored in lab experiments and animals
PHASE 1
38 vaccines
are undergoing safety tests in healthy young individuals
Phase 2
44vaccines
are being tested in broader groups of people
Phase 3
39vaccines
are in large international trials to test their impact on COVID-19
IN USE
23vaccines
are currently being offered to the general population
Phase 4
10vaccines
are being monitored in the wider population after being approved

Source: WHO

Learn more

COVID-19 vaccines

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

#VaccinesWork

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

Top VaccinesWork stories

View all stories

3 December 2021

Omg, Omicron! Why it’s too soon to panic about COVID vaccines and the new variant

We won't know whether Omicron evades COVID vaccines for another few weeks. Here's why.

3 December 2021

The groundbreaking history of the world’s first malaria vaccine

Malaria occupies a unique place in human history. Our neolithic ancestors were afflicted by it; the fall of Rome has even been partially attributed to it. During the 20th Century alone, malaria is estimated to accounted for up to five percent of…

3 December 2021

"The vaccine has done wonders”: Kenya’s experience with the world’s first malaria vaccine

The Gavi Board has approved the roll-out of RTS,S/AS01, the world’s first vaccine against malaria, a sickness which kills 260,000 children under five in sub-Saharan Africa every year. To get a sense of what this historic development might mean on…

Supported countries

Supported Countries

Our impact

Syringe >888 million children immunised
First aid locator >15 million future deaths prevented
Transitioned 16 countries transitioned from Gavi support
Billions >230 US$ billion in economic benefits for countries (2000–2020)
Children 78% of the world's children reached by routine immunisation

Our mission: save lives and protect people's health

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Our partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Like. Follow. Share.

    Subscribe to our newsletter